Robert H. Diamond

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · Clinical Gastroenterology and Hepatology · 2006 · 905 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Mucosal Immunology +6

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen et al. · The American Journal of Gastroenterology · 2012 · 780 citations

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

Stephen B. Hanauer, Carrie Wagner, Mohan Bala et al. · Clinical Gastroenterology and Hepatology · 2004 · 606 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Autoimmune Disease +11

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

Paul Rutgeerts, Robert H. Diamond, Mohan Bala et al. · Gastrointestinal Endoscopy · 2006 · 546 citations

Inflammation, Anti-inflammatory, Maintenance Treatment +6